Actively Recruiting
Inclisiran (Leqvio®) in Patients With Atherosclerotic Vascular Disease and/or Heterozygous Familial Hypercholesterolemia Treated in Spain: the INSPIRE Study
Led by Novartis Pharmaceuticals · Updated on 2026-04-16
200
Participants Needed
20
Research Sites
97 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
This study aims to address several key questions regarding the use of inclisiran in real-world clinical practice in Spain.
CONDITIONS
Official Title
Inclisiran (Leqvio®) in Patients With Atherosclerotic Vascular Disease and/or Heterozygous Familial Hypercholesterolemia Treated in Spain: the INSPIRE Study
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Aged 2 18 years or older
- Signed informed consent form
- Confirmed clinical indication for inclisiran with first dose received at least 2 months before study inclusion
- LDL-C levels assessed within 6 months before starting inclisiran after stable lipid-lowering therapy
- Statin-intolerant patients with documented side effects on 2 or more statins, including one at the lowest dose
You will not qualify if you...
- Participating in another clinical trial with treatments that could affect LDL-C levels during this study
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 20 locations
1
Novartis Investigative Site
Cadiz, Andalusia, Spain, 11009
Actively Recruiting
2
Novartis Investigative Site
Granada, Andalusia, Spain, 18014
Actively Recruiting
3
Novartis Investigative Site
Huelva, Andalusia, Spain, 21005
Actively Recruiting
4
Novartis Investigative Site
Jaén, Andalusia, Spain, 23007
Actively Recruiting
5
Novartis Investigative Site
Marbella, Andalusia, Spain, 29600
Actively Recruiting
6
Novartis Investigative Site
Mallorca, Balearic Islands, Spain, 07198
Actively Recruiting
7
Novartis Investigative Site
Puerto Real, Cadiz, Spain, 11510
Actively Recruiting
8
Novartis Investigative Site
Santander, Cantabria, Spain, 39008
Actively Recruiting
9
Novartis Investigative Site
Andújar, Jaen, Spain, 23740
Actively Recruiting
10
Novartis Investigative Site
Logroño, La Rioja, Spain, 26006
Actively Recruiting
11
Novartis Investigative Site
San Cristóbal de La Laguna, Santa Cruz De Tenerife, Spain, 38320
Actively Recruiting
12
Novartis Investigative Site
Burgos, Spain, 09006
Actively Recruiting
13
Novartis Investigative Site
Córdoba, Spain, 14004
Actively Recruiting
14
Novartis Investigative Site
Fuerteventura, Spain, 35600
Actively Recruiting
15
Novartis Investigative Site
Las Palmas GC, Spain, 35010
Actively Recruiting
16
Novartis Investigative Site
León, Spain, 24080
Actively Recruiting
17
Novartis Investigative Site
Málaga, Spain, 29010
Actively Recruiting
18
Novartis Investigative Site
Salamanca, Spain, 37007
Actively Recruiting
19
Novartis Investigative Site
Seville, Spain, 41009
Actively Recruiting
20
Novartis Investigative Site
Seville, Spain, 41013
Actively Recruiting
Research Team
N
Novartis Pharmaceuticals
CONTACT
N
Novartis Pharmaceuticals
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here